AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaxa M XR 50+500 Tablet Tablet ER

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaxa M XR 50+500 Tablet Tablet ER

Diabex Duo XR 50/500mg extended-release tablets combine two medications to manage elevated blood glucose in adults with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo XR may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Continued adherence to your doctor's dietary and exercise plan is crucial. Lifestyle modifications are paramount in diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn how to identify and treat it. This medication isn't suitable for all individuals. Inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical counsel. Interactions with other medications are possible; provide your doctor with a complete medication list for safety. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor kidney function and glucose levels throughout treatment.

Primary Ingredients of Sitaxa M XR 50+500 Tablet Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Sitaxa M XR 50+500 Tablet Tablet ER

Managing type 2 diabetes

Major Benefits of Sitaxa M XR 50+500 Tablet Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitaxa M XR 50+500 Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitaxa M XR 50+500 Tablet Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaxa M XR 50+500 Tablet Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. It's recommended to take Sitaxa M XR 50+500 Tablet ER with food.

How Sitaxa M XR 50+500 Tablet Tablet ER works:

Sitaxa M XR 50+500 Extended-Release tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to more effective blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitaxa M XR 50+500 Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Sitaxa M XR 50+500 tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the benefits against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitaxa M XR 50+500 tablets are likely unsafe for breastfeeding mothers. Preliminary human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaxa M XR 50+500 ER tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaxa M XR 50+500 ER tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Extended-release Sitaxa M XR 50+500 tablets are contraindicated in individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Sitaxa M XR 50+500 Tablet Tablet ER :

Should you forget a dose of Sitaxa M XR 50+500 Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaxa M XR 50+500 Tablet Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitaxa M XR 50+500 Tablet Tablet ER

Sitaxa M XR 50+500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitaxa M XR 50+500 Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaxa M XR 50+500 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaxa M XR 50+500 Tablet ER is contraindicated in patients with known allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitaxa M XR 50+500 ER tablets is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Sitaxa M XR 50+500 Tablet ER) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called MALA—Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaxa M XR 50+500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaxa M XR 50+500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitaxa M XR 50+500 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitaxa M XR 50+500 ER tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitaxa M XR 50+500 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitaxa M XR 50+500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaxa M XR 50+500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitaxa M XR 50+500 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitaxa M XR 50+500 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitaxa M XR 50+500 ER tablets is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaxa M XR 50+500 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaxa M XR 50+500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaxa M XR 50+500 Tablet...
149